We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Gyros to Use 360-HCP Antibodies from BioGenes


Want a FREE PDF version of This Product News?

Complete the form below and we will email you a PDF version of "Gyros to Use 360-HCP Antibodies from BioGenes"

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

BioGenes GmbH and Gyros AB have announced a cooperation for use of BioGenes’ 360-HCP antibodies in Gyrolab™ CHO-HCP Kits 2-5. The four Gyrolab™ CHO-HCP Kits, which have been introduced recently, quantify host cell proteins from Chinese hamster ovary (CHO) cells and are used in biomanufacturing processes.

360-HCP antibodies from BioGenes have been developed according to a novel approach and stand out by their ability to cover the broadest possible spectrum of antigens. 360-HCP antibodies have been generated by immunizing different species combined with an optimized antigen and antibody preparation as well as purification strategy resulting in several antibody preparations. Thus each Gyrolab™ CHO-HCP Kit contains antibody preparations that have been generated in different species using slightly different antigens.

Gyros’ kits are validated for use on the nanoliter-scale microfluidic systems Gyrolab xP workstation and Gyrolab xPlore which are in use in GLP and GMP environments in most of the top biopharma and CROs across the world.

Primarily, BioGenes has developed the 360-HCP antibodies for its enhanced generic CHO|360-HCP ELISA. Through the collaboration with Gyros the 360-HCP antibodies can now also be used in in high-throughput analyses.

The new Gyrolab™ CHO-HCP Kits will be showcased at BPI 2015 on 26-29 October in Boston, MA.

Advertisement